Scalable Life Sciences supports Toxys with the development of its corporate branding, product branding
and corporate communications strategy.

Toxys is a Dutch biotech company that provides innovative in vitro toxicity screening solutions to rapidly identify
hazardous and potential carcinogenic properties of novel compounds during the early phases of product and
drug development. The company aims to bring information to our customers that is essential to make informed
decisions on which compounds to progress in the drug/compound development pipeline, thereby contributing
to the development of better medicines and products and to reduce animal testing.

Corporate Communications, Investor Relations and Public Affairs for Life Sciences